Back to List View Graph View

Signal Transducer and Activator of Transcription 3 (STAT3)

Signal Transducer and Activator of Transcription 3 (STAT3) is a multifunctional transcription factor that serves as a central node in numerous cytokine and growth factor signaling cascades.

Where the papers sit

48 papers from the last 6 months study Signal Transducer and Activator of Transcription 3 (STAT3) directly · updated from PubMed 14 Nov 2026

Study type 0 clinical trials · 1 observational · 1 human data · 46 preclinical

Themes one subject · 1 paradigm shift

Those 48 are all about one subject.

  • STAT3-Linked Disease Biology

    STAT3-linked signaling remains a broad disease-biology and therapeutic target rather than a single translational program. Studies connect it to ferroptosis, immune resistance, metabolism, inflammation, tissue repair, and neuronal injury across cancers and noncancer diseases. Recurrent mechanisms include GPX4/SLC40A1, c-Met, IL-6, PD-L1/PDK4/GLS, NF-κB/NFATc1, and FOXO1 pathways. The shared agenda is to find selective STAT3 modulators or delivery strategies, but the cluster shows no unified clinical direction.

    48 papers

PARADIGM SHIFT

STAT3 blockade can drive ferroptosis rather than primarily apoptotic cancer-cell death

In colorectal cancer treated with the STAT3-binding curcumin analogue FLLL32 and ovarian cancer treated with atranorin, the studies found that suppressing STAT3 signaling produced ferroptotic death, with iron accumulation, lipid peroxidation, or ferroptosis-associated molecular changes outweighing conventional apoptosis as the operative mechanism. This contrasts with the set’s predominant model of STAT3 inhibition as an antiproliferative or pro-apoptotic intervention and redirects therapeutic evaluation toward ferroptosis control and susceptibility markers. 42900324Oct 42496762Jul

Papers

The 48 papers from the last 6 months that study Signal Transducer and Activator of Transcription 3 (STAT3) directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

STAT3-Linked Disease Biology (48)
  1. Curcumin analogue FLLL32 induces ferroptosis by targeting the STAT3-GPX4/SLC40A1 axis in colorectal cancer. Molecular biomedicine · 20 Oct 2026 PMID 42900324
  2. Engineered mesenchymal stem cell-derived small extracellular vesicles delivering miR-124 suppress colorectal cancer progression through EZH2 downregulation and attenuation of STAT3 signaling. Medical oncology (Northwood, London, England) · 8 Oct 2026 PMID 42848258
  3. Thieno[2,3-d]pyrimidine scaffold optimization for synergistic c-Met/STAT3 blockade: Synthesis, structure-activity relationships, in vitro potency, and apoptotic pathways in colorectal cancer. Bioorganic chemistry · 21 Sept 2026 PMID 42767173
  4. A trimethyl lock successfully stabilizes a nascent Michael acceptor for prodrug applications. Chemical communications (Cambridge, England) · 21 Sept 2026 PMID 42766013
  5. SAT1 promotes prostate cancer progression and decreases enzalutamide sensitivity by enhancing spermine catabolism. Human cell · 16 Sept 2026 PMID 42744967
  6. STAT3 inhibition for the induction of immunogenic cell death in multiple myeloma. Oncoimmunology · 15 Sept 2026 PMID 42740603
  7. Mutant p53 sensitizes KRAS-driven lung adenocarcinoma to immunotherapy by repressing SPP1. Science advances · 11 Sept 2026 PMID 42726875
  8. Amniotic fluid stem cells alleviate neuronal injury-related changes in spina bifida by inducing autophagy via regulating the FOXO1/STAT3 axis. Organogenesis · 11 Sept 2026 PMID 42723550
  9. Identification of STAT1 as a biomarker for lymph node metastasis in esophageal squamous cell carcinoma. Journal of molecular histology · 5 Sept 2026 PMID 42700277
  10. Discovery of CDK8/19 inhibitors as lead compounds for IL-6-dependent lymphoma enabled by the formal synthesis of cortistatin A. Science advances · 4 Sept 2026 PMID 42696577
  11. Targeting the PD-L1-induced PDK4/GLS metabolic axis overcomes anti-PD-1 resistance in non-small cell lung cancer. Journal for immunotherapy of cancer · 2 Sept 2026 PMID 42686373
  12. Bruceine D suppressed osteoclast formation via STAT3/NF-κB/NFATc1 signaling and protected postmenopausal osteoporosis. Molecular biology reports · 2 Sept 2026 PMID 42684554
  13. Evodiamine may inhibit insulin resistance in type 2 diabetes through IRS-1/PI3K/AKT/GLUT4 pathway. Scientific reports · 23 Aug 2026 PMID 42634086
  14. Propranolol improves cognitive function and glymphatic system recovery through STAT3/MMP2 pathway after TBI. PloS one · 21 Aug 2026 PMID 42627796
  15. Sinomenine Liposomes Alleviate Neuropathic Pain in a Spared Nerve Injury Model by Regulating Astrocyte Reactivity Associated with Inhibition of the JAK2/STAT3 Pathway. Neurochemical research · 13 Aug 2026 PMID 42593631
  16. Succinic acid inhibits hepatocyte regenerative signaling via STAT3 SH2-domain engagement. Molecular biomedicine · 7 Aug 2026 PMID 42567937
  17. CD34 and p16 expression in central nervous system solitary fibrous tumors: an exploratory clinicopathologic study. Journal of neuro-oncology · 6 Aug 2026 PMID 42560553
  18. Early versus late JAK-STAT-IFN signaling distinguishes no rejection from subclinical to clinical TCMR after liver transplantation. Science translational medicine · 5 Aug 2026 PMID 42555758
  19. Discovery of hydrazone derivatives as novel STAT3 antagonists against pancreatic and colorectal cancers. Bioorganic chemistry · 4 Aug 2026 PMID 42551351
  20. Design, synthesis, and evaluation of anti-solid-tumor activity of niclosamide-based STAT3/HDAC dual-target inhibitors. Bioorganic chemistry · 29 Jul 2026 PMID 42526131
  21. Evodiamine alleviates cancer cachexia-induced muscle atrophy by inhibiting STAT3 signaling pathway. European journal of pharmacology · 27 Jul 2026 PMID 42508712
  22. Digoxin inhibits HIF-1α to attenuate inflammation and fibrosis in thyroid eye disease. Biochemical and biophysical research communications · 24 Jul 2026 PMID 42497831
  23. Targeting Cys328 in the STAT3 DNA-binding domain with the germacrane-type sesquiterpene lactone SCP-7 inhibits colorectal Cancer growth in vitro and in vivo. Bioorganic chemistry · 24 Jul 2026 PMID 42497765
  24. Yin-Huang-Qing-Fei-Capsule derived diosgenin and its optimized nanoconjugate target STAT3 against pulmonary fibrosis. Phytomedicine : international journal of phytotherapy and phytopharmacology · 24 Jul 2026 PMID 42497519
  25. Atranorin suppresses the LUCAT1/STAT3 axis to induce ferroptotic cell death in ovarian cancer. Molecular biology reports · 24 Jul 2026 PMID 42496762
  26. Discovery of SH-17 as a pioneering STAT3/HDAC bifunctional inhibitor that simultaneously impairs Tyr705 and Ser727 phosphorylation. Bioorganic chemistry · 21 Jul 2026 PMID 42480231
  27. Effects of stattic and vinblastine on apoptosis and fatty acid profile in A549 lung cancer cells. Molecular biology reports · 20 Jul 2026 PMID 42474554
  28. FGF21 synergizes with leptin to counteract obesity-related metabolic comorbidities by reversing hepatic leptin resistance. Cell metabolism · 16 Jul 2026 PMID 42462724
  29. A template-defined TA-Fe nanoplatform enables mechanistic decoupling and lysosome-gated immunomodulation for diabetic wound healing. Journal of materials chemistry. B · 13 Jul 2026 PMID 42438451
  30. Exosomal transfer of p-AKT drives doxorubicin resistance and predicts poor prognosis in breast cancer. Molecular biology reports · 8 Jul 2026 PMID 42417926
  31. Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single Administration. Journal of medicinal chemistry · 5 Jul 2026 PMID 42402082
  32. A network pharmacology-based approach and molecular docking study to explore the therapeutic potential of a nutraceutical formula (Vernolac) in the treatment of cancer. PloS one · 1 Jul 2026 PMID 42384725
  33. Combined All-trans Retinoic Acid and Rosiglitazone Alleviates Scleroderma Fibrosis by Suppressing the STAT3/Th17 Axis. In vivo (Athens, Greece) · 30 Jun 2026 PMID 42379744
  34. SLC5A2-SRC-ERK/STAT3 signaling network in proximal tubule S1 cells mediates the renoprotective effects of dapagliflozin in obese mice. Biochemical and biophysical research communications · 27 Jun 2026 PMID 42364320
  35. Discovery of novel NQO1/STAT3/HDAC triple-target agents for the treatment of triple negative breast cancer. Bioorganic chemistry · 24 Jun 2026 PMID 42341572
  36. Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistance. Cell · 22 Jun 2026 PMID 42330950
  37. Design, synthesis, bio-evaluation, and mechanism of action of novel allosecurinine derivatives as STAT3-based antitumor agents in vitro and in vivo. Bioorganic chemistry · 20 Jun 2026 PMID 42322913
  38. Design and synthesis of 1-Phenyl-2-thioaryl-4-benzyl-5-methylimidazoles as dual STAT3/NF-κB inhibitors for triple-negative breast Cancer therapy. Bioorganic chemistry · 17 Jun 2026 PMID 42308789
  39. Design, synthesis, and biological evaluation of clovamide analogues as anti-colitis agents modulating NF-κB/STAT3/iNOS signaling. Bioorganic chemistry · 17 Jun 2026 PMID 42308787
  40. Discovery of a bamboo sap-derived dihydroxyacetophenone analog as a potent anti-inflammatory agent against acute liver failure. Bioorganic chemistry · 17 Jun 2026 PMID 42308786
  41. BP-1-102 inhibits multiple pathways of NFATc1 activation to alleviate osteoporosis and downregulate osteoclast differentiation in ovariectomized mice. Biochemical and biophysical research communications · 17 Jun 2026 PMID 42308767
  42. Type 2 Diabetes Reduces IFN-α2 and Compromises Antiviral Defense: Evidence From Mendelian Randomization and H1N1-Infected Diabetic Mice. Diabetes · 12 Jun 2026 PMID 42283639
  43. Extracellular vesicle-encapsulated miRNAs mediate monocyte-endothelial cell crosstalk to exacerbate renal injury in diabetic kidney disease. International immunopharmacology · 11 Jun 2026 PMID 42275918
  44. Network pharmacology and experimental validation reveal inhibition of the JAK2/STAT3 pathway by hydrogen sulfide in diabetic cardiomyopathy. International immunopharmacology · 8 Jun 2026 PMID 42259239
  45. Artesunate attenuates sepsis-induced myocardial injury: A preliminary investigation into the JAK2/STAT3 pathway via integrated network pharmacology and experimental validation. Biochemical and biophysical research communications · 4 Jun 2026 PMID 42241977
  46. Spatiotemporal atlas of pro-inflammatory NF-κB and anti-inflammatory STAT6 signaling using reporter mice during mRNA vaccination. Molecular therapy : the journal of the American Society of Gene Therapy · 3 Jun 2026 PMID 42231579
  47. Guanxin Ⅱ alleviates atherosclerotic comorbid depression via modulating AKT1-STAT3-TLR4 axis and ATG3-mediated autophagy. Journal of ethnopharmacology · 20 May 2026 PMID 42162760
  48. Chinese authentic herbal medicine Ganhuangcao from Southwest China mitigates influenza virus infection by inhibiting the host JAK2/STAT1 signaling pathway. Phytomedicine : international journal of phytotherapy and phytopharmacology · 20 May 2026 PMID 42160896

By study type

Observational studies and case reports (1)
  1. CD34 and p16 expression in central nervous system solitary fibrous tumors: an exploratory clinicopathologic study. Journal of neuro-oncology · 6 Aug 2026 PMID 42560553
Human data, design not indexed (1)
  1. A trimethyl lock successfully stabilizes a nascent Michael acceptor for prodrug applications. Chemical communications (Cambridge, England) · 21 Sept 2026 PMID 42766013
Preclinical: animal, cell and lab studies (46)
  1. Curcumin analogue FLLL32 induces ferroptosis by targeting the STAT3-GPX4/SLC40A1 axis in colorectal cancer. Molecular biomedicine · 20 Oct 2026 PMID 42900324
  2. Engineered mesenchymal stem cell-derived small extracellular vesicles delivering miR-124 suppress colorectal cancer progression through EZH2 downregulation and attenuation of STAT3 signaling. Medical oncology (Northwood, London, England) · 8 Oct 2026 PMID 42848258
  3. Thieno[2,3-d]pyrimidine scaffold optimization for synergistic c-Met/STAT3 blockade: Synthesis, structure-activity relationships, in vitro potency, and apoptotic pathways in colorectal cancer. Bioorganic chemistry · 21 Sept 2026 PMID 42767173
  4. SAT1 promotes prostate cancer progression and decreases enzalutamide sensitivity by enhancing spermine catabolism. Human cell · 16 Sept 2026 PMID 42744967
  5. STAT3 inhibition for the induction of immunogenic cell death in multiple myeloma. Oncoimmunology · 15 Sept 2026 PMID 42740603
  6. Mutant p53 sensitizes KRAS-driven lung adenocarcinoma to immunotherapy by repressing SPP1. Science advances · 11 Sept 2026 PMID 42726875
  7. Amniotic fluid stem cells alleviate neuronal injury-related changes in spina bifida by inducing autophagy via regulating the FOXO1/STAT3 axis. Organogenesis · 11 Sept 2026 PMID 42723550
  8. Identification of STAT1 as a biomarker for lymph node metastasis in esophageal squamous cell carcinoma. Journal of molecular histology · 5 Sept 2026 PMID 42700277
  9. Discovery of CDK8/19 inhibitors as lead compounds for IL-6-dependent lymphoma enabled by the formal synthesis of cortistatin A. Science advances · 4 Sept 2026 PMID 42696577
  10. Targeting the PD-L1-induced PDK4/GLS metabolic axis overcomes anti-PD-1 resistance in non-small cell lung cancer. Journal for immunotherapy of cancer · 2 Sept 2026 PMID 42686373
  11. Bruceine D suppressed osteoclast formation via STAT3/NF-κB/NFATc1 signaling and protected postmenopausal osteoporosis. Molecular biology reports · 2 Sept 2026 PMID 42684554
  12. Evodiamine may inhibit insulin resistance in type 2 diabetes through IRS-1/PI3K/AKT/GLUT4 pathway. Scientific reports · 23 Aug 2026 PMID 42634086
  13. Propranolol improves cognitive function and glymphatic system recovery through STAT3/MMP2 pathway after TBI. PloS one · 21 Aug 2026 PMID 42627796
  14. Sinomenine Liposomes Alleviate Neuropathic Pain in a Spared Nerve Injury Model by Regulating Astrocyte Reactivity Associated with Inhibition of the JAK2/STAT3 Pathway. Neurochemical research · 13 Aug 2026 PMID 42593631
  15. Succinic acid inhibits hepatocyte regenerative signaling via STAT3 SH2-domain engagement. Molecular biomedicine · 7 Aug 2026 PMID 42567937
  16. Early versus late JAK-STAT-IFN signaling distinguishes no rejection from subclinical to clinical TCMR after liver transplantation. Science translational medicine · 5 Aug 2026 PMID 42555758
  17. Discovery of hydrazone derivatives as novel STAT3 antagonists against pancreatic and colorectal cancers. Bioorganic chemistry · 4 Aug 2026 PMID 42551351
  18. Design, synthesis, and evaluation of anti-solid-tumor activity of niclosamide-based STAT3/HDAC dual-target inhibitors. Bioorganic chemistry · 29 Jul 2026 PMID 42526131
  19. Evodiamine alleviates cancer cachexia-induced muscle atrophy by inhibiting STAT3 signaling pathway. European journal of pharmacology · 27 Jul 2026 PMID 42508712
  20. Digoxin inhibits HIF-1α to attenuate inflammation and fibrosis in thyroid eye disease. Biochemical and biophysical research communications · 24 Jul 2026 PMID 42497831
  21. Targeting Cys328 in the STAT3 DNA-binding domain with the germacrane-type sesquiterpene lactone SCP-7 inhibits colorectal Cancer growth in vitro and in vivo. Bioorganic chemistry · 24 Jul 2026 PMID 42497765
  22. Yin-Huang-Qing-Fei-Capsule derived diosgenin and its optimized nanoconjugate target STAT3 against pulmonary fibrosis. Phytomedicine : international journal of phytotherapy and phytopharmacology · 24 Jul 2026 PMID 42497519
  23. Atranorin suppresses the LUCAT1/STAT3 axis to induce ferroptotic cell death in ovarian cancer. Molecular biology reports · 24 Jul 2026 PMID 42496762
  24. Discovery of SH-17 as a pioneering STAT3/HDAC bifunctional inhibitor that simultaneously impairs Tyr705 and Ser727 phosphorylation. Bioorganic chemistry · 21 Jul 2026 PMID 42480231
  25. Effects of stattic and vinblastine on apoptosis and fatty acid profile in A549 lung cancer cells. Molecular biology reports · 20 Jul 2026 PMID 42474554
  26. FGF21 synergizes with leptin to counteract obesity-related metabolic comorbidities by reversing hepatic leptin resistance. Cell metabolism · 16 Jul 2026 PMID 42462724
  27. A template-defined TA-Fe nanoplatform enables mechanistic decoupling and lysosome-gated immunomodulation for diabetic wound healing. Journal of materials chemistry. B · 13 Jul 2026 PMID 42438451
  28. Exosomal transfer of p-AKT drives doxorubicin resistance and predicts poor prognosis in breast cancer. Molecular biology reports · 8 Jul 2026 PMID 42417926
  29. Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single Administration. Journal of medicinal chemistry · 5 Jul 2026 PMID 42402082
  30. A network pharmacology-based approach and molecular docking study to explore the therapeutic potential of a nutraceutical formula (Vernolac) in the treatment of cancer. PloS one · 1 Jul 2026 PMID 42384725
  31. Combined All-trans Retinoic Acid and Rosiglitazone Alleviates Scleroderma Fibrosis by Suppressing the STAT3/Th17 Axis. In vivo (Athens, Greece) · 30 Jun 2026 PMID 42379744
  32. SLC5A2-SRC-ERK/STAT3 signaling network in proximal tubule S1 cells mediates the renoprotective effects of dapagliflozin in obese mice. Biochemical and biophysical research communications · 27 Jun 2026 PMID 42364320
  33. Discovery of novel NQO1/STAT3/HDAC triple-target agents for the treatment of triple negative breast cancer. Bioorganic chemistry · 24 Jun 2026 PMID 42341572
  34. Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistance. Cell · 22 Jun 2026 PMID 42330950
  35. Design, synthesis, bio-evaluation, and mechanism of action of novel allosecurinine derivatives as STAT3-based antitumor agents in vitro and in vivo. Bioorganic chemistry · 20 Jun 2026 PMID 42322913
  36. Design and synthesis of 1-Phenyl-2-thioaryl-4-benzyl-5-methylimidazoles as dual STAT3/NF-κB inhibitors for triple-negative breast Cancer therapy. Bioorganic chemistry · 17 Jun 2026 PMID 42308789
  37. Design, synthesis, and biological evaluation of clovamide analogues as anti-colitis agents modulating NF-κB/STAT3/iNOS signaling. Bioorganic chemistry · 17 Jun 2026 PMID 42308787
  38. Discovery of a bamboo sap-derived dihydroxyacetophenone analog as a potent anti-inflammatory agent against acute liver failure. Bioorganic chemistry · 17 Jun 2026 PMID 42308786
  39. BP-1-102 inhibits multiple pathways of NFATc1 activation to alleviate osteoporosis and downregulate osteoclast differentiation in ovariectomized mice. Biochemical and biophysical research communications · 17 Jun 2026 PMID 42308767
  40. Type 2 Diabetes Reduces IFN-α2 and Compromises Antiviral Defense: Evidence From Mendelian Randomization and H1N1-Infected Diabetic Mice. Diabetes · 12 Jun 2026 PMID 42283639
  41. Extracellular vesicle-encapsulated miRNAs mediate monocyte-endothelial cell crosstalk to exacerbate renal injury in diabetic kidney disease. International immunopharmacology · 11 Jun 2026 PMID 42275918
  42. Network pharmacology and experimental validation reveal inhibition of the JAK2/STAT3 pathway by hydrogen sulfide in diabetic cardiomyopathy. International immunopharmacology · 8 Jun 2026 PMID 42259239
  43. Artesunate attenuates sepsis-induced myocardial injury: A preliminary investigation into the JAK2/STAT3 pathway via integrated network pharmacology and experimental validation. Biochemical and biophysical research communications · 4 Jun 2026 PMID 42241977
  44. Spatiotemporal atlas of pro-inflammatory NF-κB and anti-inflammatory STAT6 signaling using reporter mice during mRNA vaccination. Molecular therapy : the journal of the American Society of Gene Therapy · 3 Jun 2026 PMID 42231579
  45. Guanxin Ⅱ alleviates atherosclerotic comorbid depression via modulating AKT1-STAT3-TLR4 axis and ATG3-mediated autophagy. Journal of ethnopharmacology · 20 May 2026 PMID 42162760
  46. Chinese authentic herbal medicine Ganhuangcao from Southwest China mitigates influenza virus infection by inhibiting the host JAK2/STAT1 signaling pathway. Phytomedicine : international journal of phytotherapy and phytopharmacology · 20 May 2026 PMID 42160896